Fifth industry stakeholder platform on research and development support
The European Medicines Agency (EMA) is hosting the fifth meeting of the industry stakeholder platform on research and development support on 16 November, from 13:00 to 17:00.
This is the fifth in a series of regular meetings between regulators and representatives of industry stakeholder organisations. It addresses all areas of product-development support, from scientific advice and innovation support, as well as specifics for paediatric and orphan medicines.
This meeting will focus on the evolution of the scientific advice framework, the recent launch of IRIS for scientific advice, integrated drug-device combination products (implementation of Art. 117), enhancement of the PRIME scheme, progress with the paediatric action plan and progressing the concept of patient-centred development in practice.